Literature DB >> 22772151

Combined PET/CT-perfusion in patients with head and neck cancers.

Patrick Veit-Haibach1, Daniel Schmid, Klaus Strobel, Jan D Soyka, Niklaus G Schaefer, Stephan K Haerle, Gerhard Huber, Gabriele Studer, Burkhardt Seifert, Thomas F Hany.   

Abstract

OBJECTIVES: Computed tomography perfusion (CTP) can provide information about angiogenesis and blood-flow characteristics in tumours. [18F]Fluoro-2-deoxy-D-glucose-positron emission tomography/computed tomography (FDG-PET/CT) is one of the major oncological imaging techniques which provides information about viability of the tumour cell and partly also about its aggressiveness. The aim of the study was to investigate the relationship between FDG and CTP data in patients with head and neck cancers.
MATERIALS AND METHODS: Forty-one patients with a clinically suspected head and neck cancer were prospectively included. All patients underwent a combined PET/CT with an integrated CTP examination in the area of the head and neck tumour. CTP data (BF, BV and MTT) and PET data (SUVmax, SUVmean, TLG, PETvol) were compared between tumours and (1) healthy contralateral tissue, (2) inflammatory lesions, (3) metastatic lymph nodes, and CTP data and PET data were correlated in tumours.
RESULTS: Thirty-five patients had a head and neck cancer. All CTP data were statistically different between tumours, inflammatory lesions, healthy tissue and metastatic lymph nodes; PET/CT data were in part significantly different. CTP and PET parameters were not significantly correlated.
CONCLUSION: CTP and PET parameters were not significantly correlated; thus, the additional CTP values provide additional insights into tumour behaviour and their glycolytic status.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22772151     DOI: 10.1007/s00330-012-2564-5

Source DB:  PubMed          Journal:  Eur Radiol        ISSN: 0938-7994            Impact factor:   5.315


  35 in total

1.  On the origin of cancer cells.

Authors:  O WARBURG
Journal:  Science       Date:  1956-02-24       Impact factor: 47.728

2.  64-row MDCT perfusion of head and neck squamous cell carcinoma: technical feasibility and quantitative analysis of perfusion parameters.

Authors:  Lorenzo Faggioni; Emanuele Neri; Francesca Cerri; Eugenia Picano; Veronica Seccia; Luca Muscatello; Stefano Sellari Franceschini; Carlo Bartolozzi
Journal:  Eur Radiol       Date:  2010-07-23       Impact factor: 5.315

3.  18F-FDG PET/CT for detecting nodal metastases in patients with oral cancer staged N0 by clinical examination and CT/MRI.

Authors:  Heiko Schöder; Diane L Carlson; Dennis H Kraus; Hilda E Stambuk; Mithat Gönen; Yusuf E Erdi; Henry W D Yeung; Andrew G Huvos; Jatin P Shah; Steven M Larson; Richard J Wong
Journal:  J Nucl Med       Date:  2006-05       Impact factor: 10.057

4.  Assessing tumor perfusion and treatment response in rectal cancer with multisection CT: initial observations.

Authors:  Dushyant V Sahani; Sanjeeva P Kalva; Leena M Hamberg; Peter F Hahn; Christopher G Willett; Sanjay Saini; Peter R Mueller; Ting-Yim Lee
Journal:  Radiology       Date:  2005-03       Impact factor: 11.105

5.  Inverse correlation between tumor perfusion and glucose uptake in human head and neck tumors.

Authors:  Satoshi Hirasawa; Yoshito Tsushima; Hiroyuki Takei; Hiromi Hirasawa; Ayako Taketomi-Takahashi; Akie Takano; Noboru Oriuchi; Keigo Endo
Journal:  Acad Radiol       Date:  2007-03       Impact factor: 3.173

6.  Tumor Treatment Response Based on Visual and Quantitative Changes in Global Tumor Glycolysis Using PET-FDG Imaging. The Visual Response Score and the Change in Total Lesion Glycolysis.

Authors:  Steven M. Larson; Yusuf Erdi; Timothy Akhurst; Madhu Mazumdar; Homer A. Macapinlac; Ronald D. Finn; Cecille Casilla; Melissa Fazzari; Neil Srivastava; Henry W.D. Yeung; John L. Humm; Jose Guillem; Robert Downey; Martin Karpeh; Alfred E. Cohen; Robert Ginsberg
Journal:  Clin Positron Imaging       Date:  1999-05

7.  Whole-tumor perfusion CT parameters and glucose metabolism measurements in head and neck squamous cell carcinomas: a pilot study using combined positron-emission tomography/CT imaging.

Authors:  S Bisdas; K Spicer; Z Rumboldt
Journal:  AJNR Am J Neuroradiol       Date:  2008-05-15       Impact factor: 3.825

8.  A comparison of tumour perfusion assessed by deconvolution-based analysis of dynamic contrast-enhanced CT and MR imaging in patients with squamous cell carcinoma of the upper aerodigestive tract.

Authors:  Sotirios Bisdas; Leon Medov; Mehran Baghi; George N Konstantinou; Jens Wagenblast; Choon Hua Thng; Thomas J Vogl; Tong San Koh
Journal:  Eur Radiol       Date:  2008-01-04       Impact factor: 5.315

9.  Pre-therapy 18F-FDG PET quantitative parameters help in predicting the response to radioimmunotherapy in non-Hodgkin lymphoma.

Authors:  Thomas Cazaentre; Franck Morschhauser; Maximilien Vermandel; Nacim Betrouni; Thierry Prangère; Marc Steinling; Damien Huglo
Journal:  Eur J Nucl Med Mol Imaging       Date:  2009-09-30       Impact factor: 9.236

10.  CT perfusion for the monitoring of neoadjuvant chemotherapy and radiation therapy in rectal carcinoma: initial experience.

Authors:  Massimo Bellomi; Giuseppe Petralia; Angelica Sonzogni; Maria Giulia Zampino; Andrea Rocca
Journal:  Radiology       Date:  2007-08       Impact factor: 11.105

View more
  8 in total

1.  Integrated ¹⁸F-FDG PET/perfusion CT for the monitoring of neoadjuvant chemoradiotherapy in rectal carcinoma: correlation with histopathology.

Authors:  Michael A Fischer; Bart Vrugt; Hatem Alkadhi; Dieter Hahnloser; Thomas F Hany; Patrick Veit-Haibach
Journal:  Eur J Nucl Med Mol Imaging       Date:  2014-04-24       Impact factor: 9.236

2.  Role of perfusion CT in the evaluation of functional primary tumour response after radiochemotherapy in head and neck cancer: preliminary findings.

Authors:  Stefano Ursino; Lorenzo Faggioni; Federica Guidoccio; Patrizia Ferrazza; Veronica Seccia; Emanuele Neri; Luna N Cernusco; Durim Delishaj; Riccardo Morganti; Duccio Volterrani; Fabiola Paiar; Davide Caramella
Journal:  Br J Radiol       Date:  2016-07-05       Impact factor: 3.039

3.  Dynamic contrast-enhanced computed tomography to assess early activity of cetuximab in squamous cell carcinoma of the head and neck.

Authors:  Sandra Schmitz; Denis Rommel; Nicolas Michoux; Renaud Lhommel; François-Xavier Hanin; Thierry Duprez; Jean-Pascal Machiels
Journal:  Radiol Oncol       Date:  2015-03-03       Impact factor: 2.991

4.  Utility of MRI diffusion techniques in the evaluation of tumors of the head and neck.

Authors:  José Pablo Martínez Barbero; Inmaculada Rodríquez Jiménez; Teodoro Martin Noguerol; Antonio Luna Alcalá
Journal:  Cancers (Basel)       Date:  2013-07-05       Impact factor: 6.639

5.  Combined PET/CT-perfusion in patients with head and neck cancers might predict failure after radio-chemotherapy: a proof of concept study.

Authors:  Carsten Pietsch; Felipe de Galiza Barbosa; Martin W Hüllner; Daniel T Schmid; Stephan K Haerle; Gerhard F Huber; Gabriela Studer; Thomas F Hany; Patrick Veit-Haibach
Journal:  BMC Med Imaging       Date:  2015-12-29       Impact factor: 1.930

6.  Positron Emission Tomographic Imaging Elucidates the Complex Relationship Between Glucose Uptake and Tissue Blood Flow Mechanism in Squamous Cell Oral Cancer Patients.

Authors:  Ping Xu; Yan Li; Shuyong Yang; Mingzhe Li; Chenjun Li
Journal:  Med Sci Monit       Date:  2017-09-21

7.  Glucose Metabolism and Its Complicated Relationship with Tumor Growth and Perfusion in Head and Neck Squamous Cell Carcinoma.

Authors:  Noriyuki Fujima; Tomohiro Sakashita; Akihiro Homma; Kenji Hirata; Tohru Shiga; Kohsuke Kudo; Hiroki Shirato
Journal:  PLoS One       Date:  2016-11-08       Impact factor: 3.240

Review 8.  Radiotherapy for esophageal carcinoma: dose, response and survival.

Authors:  Yijun Luo; Qingfeng Mao; Xiaoli Wang; Jinming Yu; Minghuan Li
Journal:  Cancer Manag Res       Date:  2017-12-29       Impact factor: 3.989

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.